Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth
{{output}}
Background: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely underst... ...
